These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12353669)

  • 1. Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.
    Wagner JD; Kaplan JR; Burkman RT
    Obstet Gynecol Clin North Am; 2002 Sep; 29(3):475-93. PubMed ID: 12353669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and cardioprotection: the end of the tale?
    Rosano GM; Vitale C; Silvestri A; Fini M
    Ann N Y Acad Sci; 2003 Nov; 997():351-7. PubMed ID: 14644842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormones, lipoproteins, and cardiovascular risk.
    Seed M
    Atherosclerosis; 1991 Sep; 90(1):1-7. PubMed ID: 1799395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPA and postmenopausal coronary artery atherosclerosis revisited.
    Clarkson TB; Appt SE
    Steroids; 2003 Nov; 68(10-13):941-51. PubMed ID: 14667987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and breast cancer: revisiting the issues.
    DeGregorio MW; Taras TL
    J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women.
    Williams JK; Suparto I
    ILAR J; 2004; 45(2):139-46. PubMed ID: 15111733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy for cognitive function in postmenopausal women.
    Lethaby A; Hogervorst E; Richards M; Yesufu A; Yaffe K
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003122. PubMed ID: 18254016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of ovarian hormones in cardiovascular disease.
    Medina RA; Aranda E; Verdugo C; Kato S; Owen GI
    Biol Res; 2003; 36(3-4):325-41. PubMed ID: 14631866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study].
    Kuttenn F; Gerson M; de Lignères B
    Presse Med; 2002 Mar; 31(10):468-75. PubMed ID: 11933751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender.
    Kraemer RR; Synovitz LB; Gimpel T; Kraemer GR; Johnson LG; Castracane VD
    Metabolism; 2001 Apr; 50(4):488-93. PubMed ID: 11288048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.